Resmed Inc Stock Chance of Future Stock Price Finishing Under 188.77

RMD Stock  USD 249.33  0.66  0.26%   
ResMed's future price is the expected price of ResMed instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ResMed Inc performance during a given time horizon utilizing its historical volatility. Check out ResMed Backtesting, ResMed Valuation, ResMed Correlation, ResMed Hype Analysis, ResMed Volatility, ResMed History as well as ResMed Performance.
  
At present, ResMed's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 24.07, whereas Price Book Value Ratio is forecasted to decline to 4.77. Please specify ResMed's target price for which you would like ResMed odds to be computed.

ResMed Target Price Odds to finish below 188.77

The tendency of ResMed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 188.77  or more in 90 days
 249.33 90 days 188.77 
near 1
Based on a normal probability distribution, the odds of ResMed to drop to $ 188.77  or more in 90 days from now is near 1 (This ResMed Inc probability density function shows the probability of ResMed Stock to fall within a particular range of prices over 90 days) . Probability of ResMed Inc price to stay between $ 188.77  and its current price of $249.33 at the end of the 90-day period is about 88.92 .
Considering the 90-day investment horizon ResMed has a beta of 0.26 indicating as returns on the market go up, ResMed average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ResMed Inc will be expected to be much smaller as well. Additionally ResMed Inc has an alpha of 0.0211, implying that it can generate a 0.0211 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   ResMed Price Density   
       Price  

Predictive Modules for ResMed

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ResMed Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
247.71249.43251.15
Details
Intrinsic
Valuation
LowRealHigh
213.49215.21274.26
Details
Naive
Forecast
LowNextHigh
256.35258.07259.78
Details
15 Analysts
Consensus
LowTargetHigh
167.44184.00204.24
Details

ResMed Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ResMed is not an exception. The market had few large corrections towards the ResMed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ResMed Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ResMed within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.02
β
Beta against Dow Jones0.26
σ
Overall volatility
5.36
Ir
Information ratio -0.04

ResMed Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ResMed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ResMed Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ResMed Inc has a strong financial position based on the latest SEC filings
About 61.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Peter Farrell of 1468 shares of ResMed at 249.56 subject to Rule 16b-3

ResMed Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ResMed Stock often depends not only on the future outlook of the current and potential ResMed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ResMed's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding147.6 M
Cash And Short Term Investments238.4 M

ResMed Technical Analysis

ResMed's future price can be derived by breaking down and analyzing its technical indicators over time. ResMed Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ResMed Inc. In general, you should focus on analyzing ResMed Stock price patterns and their correlations with different microeconomic environments and drivers.

ResMed Predictive Forecast Models

ResMed's time-series forecasting models is one of many ResMed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ResMed's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about ResMed Inc

Checking the ongoing alerts about ResMed for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ResMed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ResMed Inc has a strong financial position based on the latest SEC filings
About 61.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Peter Farrell of 1468 shares of ResMed at 249.56 subject to Rule 16b-3
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.416
Dividend Share
1.97
Earnings Share
7.53
Revenue Per Share
32.711
Quarterly Revenue Growth
0.111
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.